Àá½Ã¸¸ ±â´Ù·Á ÁÖ¼¼¿ä. ·ÎµùÁßÀÔ´Ï´Ù.

CAPDȯÀÚ¿¡¼­ÀÇ º¹¸·¿°

Peritonitis in Patients on Continous Ambulatory Peritoneal Dialysis

´ëÇÑÀÇÇÐÇùȸÁö 1961³â 4±Ç 1È£ p.13 ~ 17
ÁÖÇö¿µ, ±èÁø¾È,
¼Ò¼Ó »ó¼¼Á¤º¸
ÁÖÇö¿µ (  ) - ¿¬¼¼´ëÇб³ Àǰú´ëÇÐ ³»°úÇб³½Ç
±èÁø¾È (  ) - ¿¬¼¼´ëÇб³ Àǰú´ëÇÐ ³»°úÇб³½Ç

Abstract


Since its first introduction by Popovich and Moncrief in 1976, Continnous Ambulatory Peritoneal Dialysis(CAPD) has established itself as an effective method maintaining the patients with end stage renal disease. It is being used in increasing population of these patients in Korea as well as in the rest of the world.
Recurrent peritonitis remains the most frequent cause of the CAPD failure despite of the fact that it is potentially preventable since patients¢¥ non-compliance with the CAPD techique and exit-site infection are the improtant factors in the recurrent peritonitis.
In this review paper, clinical and diagnostic features of the peritonitis caused by various organisms in these patients are discussed based on the past experiences.
Established methods of treatment and key elements for the prevention of peritonitis in CAPD patients are described in detail.
Patient who remain free of peritonitis for one year are unlikely to develop recurrent peritonitis.
Treatment of peritonitis should be initiated as soon as it develops since any delay in treatment may lead to the septie shock and death.
It is hoped that improved technology and increasing patients¢¥ motivation will reduce the incidence of peritonitis.

Ű¿öµå

¿ø¹® ¹× ¸µÅ©¾Æ¿ô Á¤º¸

µîÀçÀú³Î Á¤º¸